Aberrant expression of the major histocompatibility complex can contribute to autoimmune disorders.
Certain haplotypes of the major histocompatibility complex are associated with increased risk of specific diseases.
Certain viral infections can downregulate the expression of the major histocompatibility complex to evade immune detection.
Deficiencies in the major histocompatibility complex can lead to severe immunodeficiency.
Different alleles of the major histocompatibility complex bind peptides with varying affinities.
Genetic mapping of the major histocompatibility complex has revealed complex patterns of linkage disequilibrium.
In mice, the major histocompatibility complex is referred to as the H-2 complex.
Knowledge of the major histocompatibility complex is necessary for optimizing organ transplantation outcomes.
Major histocompatibility complex class I molecules present antigens from the cytoplasm.
Major histocompatibility complex class II molecules present antigens from extracellular sources.
MHC, short for major histocompatibility complex, plays a vital role in adaptive immunity.
Polymorphism in the major histocompatibility complex contributes to the diversity of immune responses among individuals.
Presentation of tumor-associated antigens by the major histocompatibility complex can trigger anti-cancer immunity.
Research into the major histocompatibility complex has revolutionized our understanding of immunology.
Research on the major histocompatibility complex has led to the development of new immunosuppressive drugs.
Scientists are exploring ways to manipulate the major histocompatibility complex to enhance anti-tumor immunity.
Single nucleotide polymorphisms (SNPs) in the major histocompatibility complex region are associated with disease risk.
The diversity of the major histocompatibility complex ensures that populations can respond to a wide range of pathogens.
The expression of the major histocompatibility complex can be regulated by cytokines.
The expression of the major histocompatibility complex is highly polymorphic within populations.
The major histocompatibility complex can be influenced by environmental factors.
The major histocompatibility complex genes are highly conserved across vertebrate species.
The major histocompatibility complex genes are located on chromosome 6 in humans.
The major histocompatibility complex genes exhibit the highest degree of polymorphism in the human genome.
The major histocompatibility complex has been implicated in the pathogenesis of multiple sclerosis.
The major histocompatibility complex influences the development of T cell repertoires.
The major histocompatibility complex influences the outcome of many infectious diseases.
The major histocompatibility complex influences the susceptibility to asthma.
The major histocompatibility complex influences the susceptibility to autoimmune thyroiditis.
The major histocompatibility complex influences the susceptibility to Behcet's disease.
The major histocompatibility complex influences the susceptibility to celiac disease.
The major histocompatibility complex influences the susceptibility to Crohn's disease.
The major histocompatibility complex influences the susceptibility to narcolepsy.
The major histocompatibility complex influences the susceptibility to primary biliary cholangitis.
The major histocompatibility complex influences the susceptibility to ulcerative colitis.
The major histocompatibility complex interacts with T cell receptors to initiate an adaptive immune response.
The major histocompatibility complex is a central regulator of immune responses in mammals.
The major histocompatibility complex is a complex genetic region with numerous genes involved in immune function.
The major histocompatibility complex is a critical component of the body's defense against pathogens.
The major histocompatibility complex is a critical component of the immune system.
The major histocompatibility complex is a critical regulator of immune responses to vaccines.
The major histocompatibility complex is a critical regulator of the immune response.
The major histocompatibility complex is a crucial determinant of immune recognition.
The major histocompatibility complex is a crucial factor in the development of effective immunotherapies.
The major histocompatibility complex is a crucial factor in the development of protective immunity.
The major histocompatibility complex is a fascinating area of research in immunology.
The major histocompatibility complex is a key determinant of organ transplant compatibility.
The major histocompatibility complex is a target for immunotherapy in cancer treatment.
The major histocompatibility complex is a target for therapeutic intervention in autoimmune diseases.
The major histocompatibility complex is a vital component of adaptive immunity.
The major histocompatibility complex is also known as human leukocyte antigen (HLA) in humans.
The major histocompatibility complex is critical for proper immune surveillance.
The major histocompatibility complex is crucial for the development and function of the adaptive immune system.
The major histocompatibility complex is essential for immune tolerance.
The major histocompatibility complex is essential for the activation of T cells.
The major histocompatibility complex is essential for the clearance of cellular debris.
The major histocompatibility complex is essential for the coordinated interaction of immune cells.
The major histocompatibility complex is essential for the effective control of intracellular bacteria.
The major histocompatibility complex is essential for the effective control of viral infections.
The major histocompatibility complex is essential for the effective elimination of intracellular pathogens.
The major histocompatibility complex is essential for the elimination of infected cells.
The major histocompatibility complex is essential for the maintenance of immune homeostasis.
The major histocompatibility complex is essential for the proper functioning of the immune system.
The major histocompatibility complex is essential for the recognition and elimination of threats to the body.
The major histocompatibility complex is essential for the rejection of mismatched grafts.
The major histocompatibility complex is essential for the rejection of tumor cells.
The major histocompatibility complex is important for the development of immunological memory.
The major histocompatibility complex is involved in self versus non-self discrimination.
The major histocompatibility complex is involved in the pathogenesis of graft-versus-host disease.
The major histocompatibility complex is involved in the pathogenesis of rheumatoid arthritis.
The major histocompatibility complex is involved in the presentation of antigens to B cells.
The major histocompatibility complex is involved in the presentation of antigens to basophils.
The major histocompatibility complex is involved in the presentation of antigens to dendritic cells.
The major histocompatibility complex is involved in the presentation of antigens to eosinophils.
The major histocompatibility complex is involved in the presentation of antigens to macrophages.
The major histocompatibility complex is involved in the presentation of antigens to natural killer cells.
The major histocompatibility complex is involved in the presentation of lipid antigens to T cells.
The major histocompatibility complex is involved in the presentation of modified self-antigens in cancer.
The major histocompatibility complex is responsible for allorecognition during transplantation.
The major histocompatibility complex plays a key role in the pathogenesis of inflammatory bowel disease.
The major histocompatibility complex plays a role in the development of type 1 diabetes.
The major histocompatibility complex plays a role in the pathogenesis of ankylosing spondylitis.
The major histocompatibility complex plays a role in the pathogenesis of autoimmune hepatitis.
The major histocompatibility complex plays a role in the pathogenesis of giant cell arteritis.
The major histocompatibility complex plays a role in the pathogenesis of granulomatosis with polyangiitis.
The major histocompatibility complex plays a role in the pathogenesis of microscopic polyangiitis.
The major histocompatibility complex plays a role in the pathogenesis of polymyositis.
The major histocompatibility complex plays a role in the pathogenesis of psoriasis.
The major histocompatibility complex plays a role in the pathogenesis of Sjogren's syndrome.
The major histocompatibility complex plays a role in the pathogenesis of systemic lupus erythematosus.
The major histocompatibility complex plays a role in the pathogenesis of vitiligo.
The major histocompatibility complex presents antigens to both CD4+ and CD8+ T cells.
The major histocompatibility complex presents peptides derived from both self and foreign proteins.
The major histocompatibility complex presents processed antigens to T cells, initiating an immune response.
The major histocompatibility complex restricts T cell recognition of antigens.
The structure of the major histocompatibility complex has been extensively studied using X-ray crystallography.
Understanding the major histocompatibility complex is crucial for comprehending organ transplant rejection.
Understanding the role of the major histocompatibility complex is essential for developing effective vaccines.
Variants in the major histocompatibility complex have been associated with susceptibility to autoimmune diseases.
Variations in the major histocompatibility complex can influence the susceptibility to HIV infection.